GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Debt-to-Equity

Itonis (Itonis) Debt-to-Equity : 0.00 (As of Feb. 2008)


View and export this data going back to 2007. Start your Free Trial

What is Itonis Debt-to-Equity?

Itonis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2008 was $0.00 Mil. Itonis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2008 was $0.00 Mil. Itonis's Total Stockholders Equity for the quarter that ended in Feb. 2008 was $-0.07 Mil. Itonis's debt to equity for the quarter that ended in Feb. 2008 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Itonis's Debt-to-Equity or its related term are showing as below:

ITNS's Debt-to-Equity is not ranked *
in the Medical Distribution industry.
Industry Median: 0.33
* Ranked among companies with meaningful Debt-to-Equity only.

Itonis Debt-to-Equity Historical Data

The historical data trend for Itonis's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Debt-to-Equity Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Debt-to-Equity
- - -

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Itonis's Debt-to-Equity

For the Medical Distribution subindustry, Itonis's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Itonis's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Itonis's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Itonis's Debt-to-Equity falls into.



Itonis Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Itonis's Debt to Equity Ratio for the fiscal year that ended in Nov. 2007 is calculated as

Itonis's Debt to Equity Ratio for the quarter that ended in Feb. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itonis  (OTCPK:ITNS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Itonis Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Itonis's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Itonis (Itonis) Business Description

Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines